bendamustine medac 100 mg
tzamal bio-pharma ltd - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 100 mg - bendamustine - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotherapy is not appropriate.indolent non-hodgkin’s lymphomas as monotherapy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.
bendamustine medac 25 mg
tzamal bio-pharma ltd - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 25 mg - bendamustine - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotherapy is not appropriate.indolent non-hodgkin’s lymphomas as monotherapy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.
bendamustine medac 25 mg
tzamal bio-pharma ltd - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 25 mg - bendamustine - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotherapy is not appropriate.indolent non-hodgkin’s lymphomas as monotherapy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.
bendamustine hydrochloride 2,5mg/ml powder for concentrate for solution for infusion powder for concentrate for solution for infusion
accord healthcare polska sp. z o.o. - bendamustine (bendamustine hydrochloride) - powder for concentrate for solution for infusion - 2.5mg/ml
bendamustine 25 mg/ml concentrate for solution for infusion
accord healthcare ireland ltd. - bendamustine hydrochloride - concentrate for solution for infusion - bendamustine
bendamustine 25 mg powder for concentrate for solution for infusion
actavis group ptc ehf - bendamustine hydrochloride - powder for concentrate for solution for infusion - 25 milligram(s) - nitrogen mustard analogues; bendamustine - antineoplastic agents, alkylating agents - first-line treatment of chronic lymphocytic leukaemia. indolent non-hodgkin's lymphomas. front line treatment of multiple myeloma
bendamustine 25 mg powder for concentrate for solution for infusion
teva b.v. - bendamustine hydrochloride - powder for concentrate for solution for infusion - nitrogen mustard analogues; bendamustine
levact 25mg powder for concentrate for solution for infusion
astellas pharma gmbh - bendamustine hydrochloride - pdr/conc/soln for infus - 25 milligram(s) - nitrogen mustard analogues; bendamustine
levact 100mg powder for concentrate for solution for infusion
astellas pharma gmbh - bendamustine hydrochloride - pdr/conc/soln for infus - 100 milligram(s) - nitrogen mustard analogues; bendamustine
bendamustine 100 mg powder for concentrate for solution for infusion
actavis group ptc ehf - bendamustine hydrochloride - powder for concentrate for solution for infusion - 100 milligram(s) - nitrogen mustard analogues; bendamustine - antineoplastic agents, alkylating agents - first-line treatment of chronic lymphocytic leukaemia. indolent non-hodgkin's lymphomas. front line treatment of multiple myeloma.